» Articles » PMID: 26558925

Genetic Neurological Channelopathies: Molecular Genetics and Clinical Phenotypes

Overview
Date 2015 Nov 13
PMID 26558925
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Evidence accumulated over recent years has shown that genetic neurological channelopathies can cause many different neurological diseases. Presentations relating to the brain, spinal cord, peripheral nerve or muscle mean that channelopathies can impact on almost any area of neurological practice. Typically, neurological channelopathies are inherited in an autosomal dominant fashion and cause paroxysmal disturbances of neurological function, although the impairment of function can become fixed with time. These disorders are individually rare, but an accurate diagnosis is important as it has genetic counselling and often treatment implications. Furthermore, the study of less common ion channel mutation-related diseases has increased our understanding of pathomechanisms that is relevant to common neurological diseases such as migraine and epilepsy. Here, we review the molecular genetic and clinical features of inherited neurological channelopathies.

Citing Articles

Real-time multicompartment Hodgkin-Huxley neuron emulation on SoC FPGA.

Beaubois R, Cheslet J, Ikeuchi Y, Branchereau P, Levi T Front Neurosci. 2024; 18:1457774.

PMID: 39600652 PMC: 11588749. DOI: 10.3389/fnins.2024.1457774.


Voltage-Gated Ion Channel Compensatory Effect in DEE: Implications for Future Therapies.

Shabani K, Krupp J, Lemesre E, Levy N, Tran H Cells. 2024; 13(21.

PMID: 39513870 PMC: 11544952. DOI: 10.3390/cells13211763.


Targeted therapy improves cellular dysfunction, ataxia, and seizure susceptibility in a model of a progressive myoclonus epilepsy.

Feng H, Clatot J, Kaneko K, Flores-Mendez M, Wengert E, Koutcher C Cell Rep Med. 2024; 5(2):101389.

PMID: 38266642 PMC: 10897515. DOI: 10.1016/j.xcrm.2023.101389.


Characterizing Genotypes and Phenotypes Associated with Dysfunction of Channel-Encoding Genes in a Cohort of Patients with Intellectual Disability.

Ehtesham N, Mosallaei M, Beheshtian M, Khoshbakht S, Fadaee M, Vazehan R Arch Iran Med. 2023; 25(12):788-797.

PMID: 37543906 PMC: 10685845. DOI: 10.34172/aim.2022.124.


Contribution of Axon Initial Segment Structure and Channels to Brain Pathology.

Garrido J Cells. 2023; 12(8).

PMID: 37190119 PMC: 10137252. DOI: 10.3390/cells12081210.


References
1.
Gloyn A, Pearson E, Antcliff J, Proks P, Bruining G, Slingerland A . Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med. 2004; 350(18):1838-49. DOI: 10.1056/NEJMoa032922. View

2.
Schols L, Kruger R, Amoiridis G, Przuntek H, Epplen J, Riess O . Spinocerebellar ataxia type 6: genotype and phenotype in German kindreds. J Neurol Neurosurg Psychiatry. 1998; 64(1):67-73. PMC: 2169927. DOI: 10.1136/jnnp.64.1.67. View

3.
Lehmann-Horn F, Kuther G, Ricker K, Grafe P, Ballanyi K, Rudel R . Adynamia episodica hereditaria with myotonia: a non-inactivating sodium current and the effect of extracellular pH. Muscle Nerve. 1987; 10(4):363-74. DOI: 10.1002/mus.880100414. View

4.
Cregg R, Cox J, Bennett D, Wood J, Werdehausen R . Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV 1.7 sodium channels. Br J Pharmacol. 2014; 171(19):4455-63. PMC: 4209151. DOI: 10.1111/bph.12788. View

5.
Fujiwara T, Sugawara T, Mazaki-Miyazaki E, Takahashi Y, Fukushima K, Watanabe M . Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. Brain. 2003; 126(Pt 3):531-46. DOI: 10.1093/brain/awg053. View